SK Bioscience Co. Ltd. 13D and 13G filings for Novavax, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-20 2:35 pm Unchanged | 2024-05-10 | 13G | Novavax, Inc. NVAX | SK Bioscience Co. Ltd. | 6,500,000 4.600% | 0 (Unchanged) | Filing |
| 2023-08-18 06:08 am Purchase | 2023-08-08 | 13G | Novavax, Inc. NVAX | SK Bioscience Co. Ltd. | 6,500,000 6.400% | 6,500,000![]() (New Position) | Filing |
